Resverlogix expanded phase 2b clinical trial for COVID-19 treatment with first site in Brazil and second in Canada
On Feb. 17, 2022, Resverlogix announced that the first Brazilian site had been initiated for its Phase 2b…
On Feb. 17, 2022, Resverlogix announced that the first Brazilian site had been initiated for its Phase 2b…
On Mar. 25, 2021, McGill University researchers led by Bratislav Misic announced a direct link between gene expression…
In 1959, University of Western Ontario researchers Dr. Charles Beer and Dr. Robert L. Noble developed the anti-cancer…